Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Clinical trial NCT02638766 · COMPLETED
Trial details
- NCT number
- NCT02638766
- Sponsor
- Grupo Espanol de Investigacion en Sarcomas
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2021-08-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.